Decompensation Detection Study

N/ACompletedNCT00583089

Boston Scientific Corporation699 enrolled

Overview

To gather data and analyze decompensation events.

Study Type

OBSERVATIONAL

Enrollment

699

Conditions

Heart Failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients implanted with an approved Guidant CRT-D HF device programmed to CRT therapy in VDD or DDD mode. * Patients prescribed to the LATITUDE(R) system configured for at least weekly device interrogations and symptoms reporting. * Patients willing to use the LATITUDE(R) enabled weight scale. Exclusion Criteria: * Patients that require adaptive rate pacing (rate-responsive modes). * Patients that have received routinely scheduled intravenous inotropic therapy as part of their drug regimen within the past 90 days. * Both

Outcomes

Primary Outcomes

Data collection and analysis.

Time frame: End of patient follow up.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.